Research graph
References from MRI-derived features reveal recurrence heterogeneity in VI-RADS 2 non-muscle-invasive bladder cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice
10.1038/s41571-023-00744-3 · 2023 · External reference
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
10.3322/caac.21660 · 2021 · External reference
Advances in diagnosis and treatment of bladder cancer
10.1136/bmj-2023-076743 · 2024 · External reference
European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-a summary of the 2024 guidelines update
10.1016/j.eururo.2024.07.027 · 2024 · External reference
VI-RADS score and tumor contact length in MRI: a potential method for the detection of muscle invasion in bladder cancer
10.1016/j.clinimag.2021.02.026 · 2021 · External reference
Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System)
10.1016/j.eururo.2018.04.029 · 2018 · External reference
Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center
10.1007/s00330-019-06117-8 · 2019 · External reference
Multiparametric MRI-based VI-RADS: can it predict 1- to 5-year recurrence of bladder cancer
10.1007/s00330-023-10387-8 · 2024 · External reference
The role of VI-RADS scoring criteria for predicting oncological outcomes in bladder cancer
10.1007/s00345-024-05101-2 · 2024 · External reference
Diffusion-weighted MRI in the body: applications and challenges in oncology
10.2214/ajr.06.1403 · 2007 · External reference
Significance of normalized apparent diffusion coefficient in the Vesical Imaging-Reporting and Data System for diagnosing muscle-invasive bladder cancer
10.1002/jmri.29208 · 2024 · External reference
Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade
10.1148/radiol.2511080873 · 2009 · External reference
Diagnostic accuracy and interobserver agreement for the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer: a multireader validation study
10.1016/j.eururo.2019.03.012 · 2019 · External reference
A study on predicting recurrence of non-muscle-invasive bladder cancer within 2years using mp-MRI radiomics
10.1186/s12885-025-14753-1 · 2025 · External reference
Diagnostic accuracy of multiparametric MRI for local staging of bladder cancer: a systematic review and meta-analysis
10.1016/j.urology.2020.07.021 · 2020 · External reference
Can pretreatment ADC values predict recurrence of bladder cancer after transurethral resection
10.1016/j.ejrad.2012.06.009 · 2012 · External reference
VI-RADS in bladder cancer: overview, pearls and pitfalls
10.1016/j.ejrad.2022.110666 · 2023 · External reference
VI-RADS for bladder cancer: current applications and future developments
10.1002/jmri.27361 · 2022 · External reference
European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)
10.1016/j.eururo.2021.08.010 · 2022 · External reference
Predicting response to intravesical therapy in non-muscle-invasive bladder cancer
10.1016/j.euf.2018.07.032 · 2018 · External reference
Prognostic role of different T1 substaging systems on recurrence and progression in non-muscle-invasive bladder cancer: a systematic review and meta-analysis
10.1016/j.euo.2025.10.012 · 2026 · External reference
